4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001388492.1(HTT):​c.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA​(p.Gln28_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0040 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0015 ( 19 hom. )
Failed GnomAD Quality Control

Consequence

HTT
NM_001388492.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 4.84

Publications

6 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 2654593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00405 (534/131868) while in subpopulation AMR AF = 0.00619 (83/13410). AF 95% confidence interval is 0.00511. There are 5 homozygotes in GnomAd4. There are 223 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln28_Gln37dup disruptive_inframe_insertion Exon 1 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln28_Gln37dup disruptive_inframe_insertion Exon 1 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.81_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln28_Gln37dup disruptive_inframe_insertion Exon 1 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.00404
AC:
533
AN:
131770
Hom.:
5
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00311
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00620
Gnomad ASJ
AF:
0.00313
Gnomad EAS
AF:
0.00121
Gnomad SAS
AF:
0.00153
Gnomad FIN
AF:
0.00149
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00486
Gnomad OTH
AF:
0.00501
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00150
AC:
1834
AN:
1225782
Hom.:
19
Cov.:
0
AF XY:
0.00160
AC XY:
976
AN XY:
608110
show subpopulations
African (AFR)
AF:
0.00132
AC:
34
AN:
25812
American (AMR)
AF:
0.00330
AC:
100
AN:
30296
Ashkenazi Jewish (ASJ)
AF:
0.00185
AC:
42
AN:
22736
East Asian (EAS)
AF:
0.00148
AC:
43
AN:
29096
South Asian (SAS)
AF:
0.00192
AC:
139
AN:
72228
European-Finnish (FIN)
AF:
0.00215
AC:
70
AN:
32494
Middle Eastern (MID)
AF:
0.00185
AC:
7
AN:
3784
European-Non Finnish (NFE)
AF:
0.00137
AC:
1310
AN:
957500
Other (OTH)
AF:
0.00172
AC:
89
AN:
51836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00405
AC:
534
AN:
131868
Hom.:
5
Cov.:
0
AF XY:
0.00352
AC XY:
223
AN XY:
63418
show subpopulations
African (AFR)
AF:
0.00313
AC:
111
AN:
35514
American (AMR)
AF:
0.00619
AC:
83
AN:
13410
Ashkenazi Jewish (ASJ)
AF:
0.00313
AC:
10
AN:
3190
East Asian (EAS)
AF:
0.00121
AC:
5
AN:
4124
South Asian (SAS)
AF:
0.00153
AC:
6
AN:
3910
European-Finnish (FIN)
AF:
0.00149
AC:
11
AN:
7368
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.00486
AC:
299
AN:
61484
Other (OTH)
AF:
0.00496
AC:
9
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HTT: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71180116; hg19: chr4-3076603; API